Validity and Reliability of Modified Box and Block Test and Targeted Box and Block Test in Patients With Stroke

NCT ID: NCT05215795

Last Updated: 2023-01-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-09-01

Study Completion Date

2022-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of our study is investigated validity and reliabilty of Modified Box and Block Test and Targeted Box and Block Test in patients with stroke.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Fifty patients with stroke will included in the study. Box and Block Test, Modified Box and Block Test, Targeted Box and Block Test, 9 Hole Peg Test, Fugl-Meyer Assessment of the upper extremity will used to assess upper extremity. To evaluate validity between Modified and Targeted Box and Block Tests and Box and Block Test, 9 Hole Peg Test, Fugl-Meyer Assessment will used to correlation analysis tests. The investigator will evaluate after one week to test-retest reliability to patients. Other pyhsiotherapist will evaluate to patients inter-rater reliability.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosed with stroke and in the chronic phase (having been diagnosed with stroke at least 6 months ago),
* Over 18 years old,
* Mini Mental Test score ≥ 24 points,
* Able to grasp and release a 2.5 cm cube on both upper extremities,
* Brunnstrom Upper Extremity Staging ≥ 3
* Modified Ashworth Scale ≤ 2,
* Able to sit independently in a chair for 2 minutes

Exclusion Criteria

* Having a neurological disease other than stroke
* Have had surgery in the last 6 months
* Severely affected upper extremity
* Uncooperative with physiotherapist
* Patients with neglect, aphasia and hemianopsia
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kutahya Health Sciences University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lütfiye AKKURT, MSc

Lecturer, MSc PT

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lütfiye AKKURT, MSc

Role: PRINCIPAL_INVESTIGATOR

Kutahya Health Sciences University

Cihan Caner AKSOY, PhD

Role: STUDY_DIRECTOR

Kutahya Health Sciences University

Fatıma YAMAN, MD

Role: PRINCIPAL_INVESTIGATOR

Kutahya Health Sciences University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kutahya Health Sciences University

Kütahya, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KutahyaHSU3

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.